NCT06690892 Investigating the Effects of Beef Consumption on Cognitive and Brain Health
| NCT ID | NCT06690892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nebraska Lincoln |
| Condition | Dietary Intervention |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2025-09-22 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2025-09-22 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if eating more beef will lead to better cognition and a healthier brain in younger adults. The main questions it aims to answer are: * Does eating more beef lead to higher scores on cognitive tests and better quality of life? * Does eating more beef lead to better brain function? Researchers will compare participants in the experimental group (participants who will eat 25 ounces of beef every week during the dietary intervention) to control participants (participants who will eat 5 ounces of beef every week during the dietary intervention). Participants will: * Be instructed to prepare and consume ready-to-eat beef meals along with their regular diet and not eat any more beef other than what they are given * Visit the study facilities once every week to pick up ready-to-eat beef meals; and complete a brief survey every week to track their consumption of the provided beef meals, and a dietary survey every 4 weeks * Visit the study facilities before and after the 12-week of intervention period for researchers to study them
Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study * Males and females; Age 19-24 * Willingness to adhere to the ready-to-eat beef intervention regimen * Lives within 75 miles of Lincoln, NE * BMI between 18.5 and 39.9 * Not pregnant or nursing * No history of cognitive or metabolic diseases indicated by diagnosis, including neurodegenerative disease, stroke, Type 1 and 2 diabetes, metabolic syndrome, cardiovascular disease, liver disease, kidney disease, and cancer * No history of eating or anxiety disorders * Willing to discontinue dietary supplement use throughout the duration of the study, if they are consuming supplement at the time of the registration * No known contraindication to MRI scans as determined by the MRI screening survey questions Exclusion Criteria: * Current use of medications that may affect their responses to dietary intervention, such as amphetamines, antidepressants, anti-diabetic medications, laxatives, antibiotics, statins and diuretics. * Known intolerance or allergy to beef * Current use of nicotine products, including vaping * Previous use of nicotine products, including vaping, within the recent 6 months at the time of pre-screening
Contact & Investigator
Aron Barbey, PhD
PRINCIPAL INVESTIGATOR
University of Nebraska Lincoln
Frequently Asked Questions
Who can join the NCT06690892 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 24 Years, studying Dietary Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06690892 currently recruiting?
Yes, NCT06690892 is actively recruiting participants. Contact the research team at dschultz14@unl.edu for enrollment information.
Where is the NCT06690892 trial being conducted?
This trial is being conducted at Lincoln, United States.
Who is sponsoring the NCT06690892 clinical trial?
NCT06690892 is sponsored by University of Nebraska Lincoln. The principal investigator is Aron Barbey, PhD at University of Nebraska Lincoln. The trial plans to enroll 240 participants.